Loading clinical trials...
Loading clinical trials...
An Open Label, Safety Study to Assess the Potential for Adrenal Suppression Following Treatment with DSXS (Taro Pharmaceuticals U.S.A., Inc.) in Patients with Plaque Psoriasis
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sun Pharmaceutical Industries, Inc.
NCT07474792 · Plaque Psoriasis
NCT06979453 · Plaque Psoriasis
NCT07116967 · Plaque Psoriasis
NCT07250802 · Plaque Psoriasis
NCT07449702 · Plaque Psoriasis
Taro Pharmaceuticals USA Inc.
Hawthorne, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions